Description: Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.
Home Page: www.maccura.com
Hi-tech Zone
Chengdu,
China
Phone:
86 28 8173 1888
Officers
| Name | Title |
|---|---|
| Mr. Wu Mingjian | GM & Director |
| Ms. Ping Yu | Admin. Director & Mang. of Human Resource Department |
| Mr. Shengguo Xu | Director of Marketing & Director |
| Ms. Wei Shi | Sec. & Director of Strategic Investment |
| Mr. Zhen Wang | Production Director |
| Ms. Hui Yang | Director of Production - Reagents |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 14.2734 |
| Price-to-Book MRQ: | 1.9697 |
| Price-to-Sales TTM: | 3.3232 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2901 |